Publication:
Proteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures

Simple item page
dc.contributor.authorFranciosa, G
dc.contributor.authorSmits, JGA
dc.contributor.authorMinuzzo, S
dc.contributor.authorMartinez-Val, A
dc.contributor.authorIndraccolo, S
dc.contributor.authorOlsen, JV
dc.date.accessioned2026-02-25T13:26:19Z
dc.date.available2026-02-25T13:26:19Z
dc.date.issued2021-05-04
dc.description.peerreviewedSí
dc.description.tableofcontentsThe authors thank all lab members for feedback, especially Alexander Hogrebe, Dorte Bekker-Jensen, Nadezhda Doncheva, and Jose Romero Herrera. Work at The Novo Nordisk Foundation Center for Protein Research is funded in part by a generous donation from the Novo Nordisk Foundation (Grant number NNF14CC0001). The proteomics technology developments applied was part of a project that has received funding from the European Union's Horizon 2020 research and innovation program under grant agreements: MSmed-686547, EPIC-XS-823839, and ERC synergy grant 810057-HighResCells.
dc.identifier.citationNat Commun. 2021 May 4;12(1):2507.
dc.identifier.journalNATURE COMMUNICATIONS
dc.identifier.urihttps://hdl.handle.net/20.500.12105/27271
dc.language.isoeng
dc.relation.isreferencedbyPubMed
dc.relation.publisherversion10.1038/s41467-021-22787-9
dc.repisalud.institucionCNIC
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleProteomics of resistance to Notch1 inhibition in acute lymphoblastic leukemia reveals targetable kinase signatures
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Proteomics of resistance to Notch1_Nat Commun_2021.pdf
Size:
5.61 MB
Format:
Adobe Portable Document Format
Download

Collections

Grupos de investigación